Manufacturer record
CMG Biotech Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
15 batches manufactured by CMG Biotech Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between March 2019 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: CT24251187B, Furosemide & Spironolactone Tablets (exp Sep 2026). DTL, Bengaluru, Karnataka (state lab) found it not of standard quality: Description as per Schedule V of Drugs and Cosmetics act 1940 & Rules 1945 thereunder. Listed in the June 2026 alert.
Records by type
15 records linked to CMG Biotech Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Furosemide & Spironolactone Tablets | Batch CT24251187BMfg Oct 2024 · Exp Sep 2026 | Description as per Schedule V of Drugs and Cosmetics act 1940 & Rules 1945 thereunder.Description | DTL, Bengaluru, KarnatakaState lab | Jun 2026 |
| Pre & Probiotic Capsules | Batch CC25260109AMfg Aug 2025 · Exp Jan 2027 | The sample does not conform to claim with respect to the identification of Clostridium butyricum and Assay of Clostridium butyricum,Assay | CDL, KolkataCDSCO lab | Mar 2026 |
| Atorvastatin Tablets IP 20mg | Batch CT24250048Mfg Apr 2024 · Exp Mar 2026 | Assay and Dissolution testAssay | SDT&RL, BhubaneswarState lab | Dec 2025 |
| Valsartan Tablets IP | Batch CT24250295Mfg May 2024 · Exp Apr 2026 | DissolutionDissolution | CDTL, IndoreCDSCO lab | Jul 2025 |
| Doxepin Hydrochloride Capsules IP (Doxon 75) | Batch CC23240161Mfg Feb 2024 · Exp Jan 2026 | Dissolution and Assay of Doxepin Hydrochloride.Assay | CDL, KolkataCDSCO lab | Jul 2025 |
| Betahistine Dihydrochloride Tablet I.P (CGHEST-8) | Batch CT24250284AMfg May 2024 · Exp Apr 2026 | DescriptionDescription | CDTL- IndoreCDSCO lab | May 2025 |
| Atorvastatin Tablets IP (GATOVAS- 20) | Batch CT24250423Mfg Jun 2024 · Exp May 2026 | "Related substances"Related substances | CDTL-MumbaiCDSCO lab | Mar 2025 |
| Fexofenadine Hydrochloride Tablets IP (MANOFEX-180) | Batch CT24250327 AMfg May 2024 · Exp Apr 2026 | DissolutionDissolution | CDL KolkataCDSCO lab | Dec 2024 |
| Ciprofloxcin Tablets IP 250 mg | Batch CT23241818Mfg Feb 2024 · Exp Jan 2026 | Dissolution of CiprofloxcinDissolution | RDTL GuwahatiCDSCO lab | Oct 2024 |
| BETAHISTINE DIHYDROCHLO RIDE TABLETS IP(CGHEST-8) | Batch CT2425028 4BMfg Mar 2024 · Exp Apr 2026 | On the received sample presence of spots were observed which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discolouration-NSQDescription | State Lab PuducherryState lab | Oct 2024 |
| Fexofenadine Hydrochloride Tablets IP (MANOFEX-180 TABLETS) | Batch CT232407 15AMfg Aug 2023 · Exp Jul 2025 | Dissolution (In 10 minutes) and (in 30 minutes)Dissolution | RDTL ChandigarhCDSCO lab | Jun 2024 |
| Manokast 5 (Montelukast Tablets IP) | Batch CT22230271AMfg May 2022 · Exp Apr 2024 | Assay of MontelukastAssay | CDL KolkataCDSCO lab | Jun 2023 |
| CGTROM-1 (Nicoumalone Tablets IP) | Batch CT22231818Mfg Mar 2023 · Exp Feb 2025 | Related substancesRelated substances | CDL KolkataCDSCO lab | Jun 2023 |
| Gatoline-100 (Doxycycline Capsules I.P.) | Batch CC-200140Mfg Dec 2020 · Exp Nov 2022 | AssayAssay | CDL KolkataCDSCO lab | Mar 2022 |
| Sodium Alendronate Tablets (GATOFOS- 35 TABLETS) | Batch CT-017893Mfg Mar 2018 · Exp Feb 2020 | Assay of Sodium Alendronate calculated as Alendronic AcidAssay | RDTL ChandigarhCDSCO lab | Mar 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.